Click here to skip navigation

EQIPP: STEP Up Diabetes Care







ACCME Accreditation Statement

The American Academy of Pediatrics (AAP) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.







The AAP designates this enduring material for a maximum of 7.50 AMA PRA Category 1 Credits(s)TM . Physicians should claim only the credit commensurate with the extent of their participation in the activity.







The AAP designates this PI CME activity for a maximum of 20 AMA PRA Category 1 Credits(s)TM .  Physicians should claim only the credit commensurate with the extent of their participation in the activity.







This Performance Improvement CME program has been reviewed and is approved for a maximum of 20.00 AAPA Category 1 PI-CME credits by the Physician Assistant Review Panel. All stages of the activity must be completed for a participant to claim any credit. Approval is valid until June 4, 2016. Physician Assistants should claim only the credit commensurate with the extent of their participation in the activity. This program was planned in accordance with AAPA’s CME Standards.







This program is approved for 27.50 NAPNAP CE contact hours of which 5.0 contain pharmacology (Rx) content per the National Association of Pediatric Nurse Practitioners (NAPNAP) Continuing Education Guidelines.







This activity is acceptable for a maximum of 27.50 credits. These credits can be applied toward the AAP CME/CPD Award available to Fellows and Candidate Members of the AAP.

Course Goals

The goal of this EQIPP: STEP Up Diabetes Care course is to help you create plans for improvement and to address gaps identified in key activities of diabetes care. These activities focus on improving ongoing medical care and patient self-management education and support. You will collect baseline and follow-up data as you work to improve care and processes through Plan, Do, Study, and Act (PDSA) cycles.

Learning Objectives

By the end of this course, you will be familiar with the following:

    • The guidelines for pediatric diabetes care that direct recommended actions for the screening, diagnosis, and treatment of diabetes in the pediatric population
    • The policies that outline the responsibilities for care coordination between the pediatric medical home, the diabetes care team, and other providers

Recognize how these key activities contribute to high-quality ongoing diabetes care and implement ideas for change to improve your delivery of care to patients in your practice

Measure and improve diabetes care delivery and processes for the above key activities by doing the following: 

    1. Confirm the diagnosis of diabetes. 
    2.  Form a multidisciplinary diabetes care team that considers the needs of the individual patient and develop processes for regular, ongoing communication among team members.
    3. Identify and address psychosocial issues including concerns about adherence to treatment regimens.
    4. Define, prioritize, and review individualized diabetes goals.
    5. Provide diabetes education at every visit.
    6. Demonstrate ongoing completion of essential ADA-recommended diabetes assessments and measurements. Such assessments are generally completed by the pediatric endocrinologist and diabetes care team.
    7. Ensure appropriate influenza and pneumococcal immunizations are recommended/administered—generally the responsibility of the general pediatrician.

Measure and improve diabetes care delivery and processes for the above key activities by doing the following:

    • Collect and analyze baseline data to establish a starting point for improvement.
    • Identify one or more performance gaps in key activities of diabetes care.
    • Create an improvement plan for closing identified performance gap(s) and document the improvement idea to be tested:
      • AIM: What are we trying to improve or accomplish?
      • MEASURES: How will we know that a change made is an improvement?
      • CHANGES: What changes can we make that will result in improvement?
    • Test ideas quickly on a small scale to determine if the changes lead to improvement.
    • Collect and analyze follow-up data to measure the results of the test.
    • Determine how to sustain successful changes and how to systematically integrate them into the culture, processes, and workflow of your practice .
    • Create additional improvement plans and repeat PDSA cycles until you reach the maximum potential of providing optimal diabetes care in your practice.

Disclosure of Financial Relationships and Resolution of Conflicts of Interest for AAP CME Activities

The AAP CME program aims to develop, maintain, and improve the competence, skills, and professional performance of pediatricians and pediatric healthcare professionals by providing quality, relevant, accessible, and effective educational experiences that address gaps in professional practice. The AAP CME program strives to meet participants' educational needs and support their life-long learning with a goal of improving care for children and families. (AAP CME Program Mission Statement, September 2010)







The AAP recognizes that there are a variety of financial relationships between individuals and commercial interests that require review to identify possible conflicts of interest in a CME activity. The “AAP Policy on Disclosure of Financial Relationships and Resolution of Conflicts of Interest for AAP CME Activities” is designed to ensure quality, objective, balanced, and scientifically rigorous AAP sponsored or jointly sponsored Continuing Medical Education (CME) activities by identifying and resolving all potential conflicts of interest prior to the confirmation of service of those in a position to influence and/or control CME content.







All AAP CME activities will strictly adhere to the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support: Standards to Ensure the Independence of CME Activities. In accordance with these Standards, the following decisions will be made free of the control of a commercial interest: identification of CME needs, determination of educational objectives, selection and presentation of content, selection of all persons and organizations that will be in a position to control the content, selection of educational methods, and evaluation of the CME activity (ACCME Standard 1.1).







The purpose of this policy and its associated procedures is to ensure all potential conflicts of interest are identified and mechanisms to resolve them prior to the CME activity are implemented in ways that are consistent with the public good.

The content of this CME activity does not necessarily reflect the views or policies of the AAP.

Disclosure of Financial Relationships

All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. *Commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.







 Name

Relevant Financial Relationship

(Please indicate Yes, or No) 

Name of Commercial Interest(s)*

(Please list name(s) of entity)

AND

Nature of Relevant Financial Relationship(s)

(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds excluding mutual funds, Consultant, Other - identify) 

Disclosure of Off-Label (Unapproved)/Investigational Uses of Products







AAP CME faculty are required to disclose to the AAP and to learners when they plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an unapproved or “off-label” use of an approved device or pharmaceutical.

 

(Do intend to discuss or Do not intend to discuss)  

Heow Ch’ng Ang

No

None

Do not intend to discuss

Dorothy Becker, MD, FAAP (SME)

 No

None

Do not intend to discuss

Stephen Cook, MD, FAAP  (SME)

 No

None

 

Do intend to discuss –

The off-label use of fluoride varnish in young children

Kenneth Copeland, MD FAAP (SME)

 No

1. I have a Honorarium relationship with NovoNordisk Pharmaceuticals

Please note: 2010 served on national Advisory Board

Added 08/03/2011 by Kenneth Copeland, source=Web Response

2. I have a Paid Consultant relationship with Daiichi Sankyo

Please note: I am a consultant for Daiichi Sankyo and receive an honorarium.

Added 08/04/2011 by Diane Aiello, source=Electronic Document

Removed 08/04/2011 by Diane Aiello, source=Electronic Document

 

3. I have a Honorarium relationship with Daiichi Sankyo

Please note: I am a consultant for Daiichi Sankyo and receive an honorarium.

 Do not intend to discuss

Marilyn Dumont-Driscoll, MD, FAAP (SME)

 No

None

 

Do intend to discuss –

We may discuss the use of fluoride varnish for caries prevention as part of EQIPP, which is an off label use in the US.

Diane Guerriero, Instructional Designer

 No

 None

 Do intend to discuss

Melissa Hendricks, MD (SME)

 No

 None

 Do not intend to discuss

Lori Laffel, MD, FAAP (SME)

 No

1. I have a Paid Consultant relationship with Lilly

Please note: consultant on insulin study in pediatric patients

Added 08/10/2011 by Lori M. Laffel, source=Web Response

2. I have a Paid Consultant relationship with Sanofi Aventis

Please note: advisory board

Added 08/10/2011 by Lori M. Laffel, source=Web Response

3. I have a Research Grant relationship with Bayer

Please note: investigator initiated educational grant

Added 08/10/2011 by Lori M. Laffel, source=Web Response

4. I have a Paid Consultant relationship with Menarini

Please note: consultant on sick day management in diabetes

Added 08/10/2011 by Lori M. Laffel, source=Web Response

5. I have a Paid Consultant relationship with Bristol Meyers Squibb

Please note: consultant on study of type 2 diabetes in youth

Added 08/10/2011 by Lori M. Laffel, source=Web Response

6. I have a Paid Consultant relationship with Johnson & Johnson

Please note: consultant on pediatric diabetes

 Do not intend to discuss

 

Laura Laskosz, MPH, Staff

 No

 None

 Do not intend to discuss

Lynne Levitsky,

MD, FAAP

 No

  1. I have a Research Grant relationship with Pfizer

Please note: growth hormone study

Added 08/02/2011 by Lynne Levitsky, source=Web Response

2. I have a Research Grant relationship with NovoNordisk

Please note: growth hormone study

Added 08/02/2011 by Lynne Levitsky, source=Web Response

3. I have a Research Grant relationship with Eli Lilly

Please note: growth hormone study

Added 08/02/2011 by Lynne Levitsky, source=Web Response

4. I have a Honorarium relationship with Novonordisk Japan

Please note: Talk about history of Pedi endo at MGH to Japanese Pedi endos

Added 08/02/2011 by Lynne Levitsky, source=Web Response

5. I have a Paid Consultant relationship with Galapagos Ltd

Please note: SARM drug for use in muscular dystrophy

Added 08/02/2011 by Lynne Levitsky, source=Web Response

6. My spouse/partner has a Paid Consultant relationship with Onyx Heart Valve Company

Please note: on review board for a new heart valve

 Do not intend to discuss

Lori Morawski, MPH, CHES, Staff

 No

 None

 Do not intend to discuss

Tamiko O’Brill, MS, Staff

 No

 None

 Do not intend to discuss

Leslie Plotnick, MD, FAAP

 No

 None

 Do not intend to discuss

Robert Schwartz, MD, FAAP

 No

 None

 Do not intend to discuss

Janet Silverstein, MD, FAAP

No

1. I have a Research Grant relationship with sanofi aventis

Please note: Small grant for research study performed at Diabetes Camp

Added 08/16/2011 by Janet Silverstein, source=Web Response

2. I have a Honorarium relationship with Genentech

Please note: I get paid for reviewing grants for Genentech once a year. Not related to diabetes issues but still there is some  $$.

Do not intend to discuss

 

Commercial Supporters

The EQIPP: Step Up Diabetes Care course was produced by the American Academy of Pediatrics. The work was supported by the Eli Lilly.







Product-Specific Advertising

No product-specific advertising of any type appears in this activity. No links to product websites appear in this activity.

List of Diabetes Principal Faculty and Credentials

Dorothy Becker, MD, FAAP







Stephen Cook, MD, MPH, FAAP







Kenneth Copeland, MD, FAAP







Marilyn Dumont-Driscoll, MD, FAAP







Melissa Hendricks, MD







Lori Laffel, MD, FAAP







Lynne Levitsky, MD, FAAP







Leslie Plotnick, MD, FAAP







Janet Silverstein, MD, FAAP







AAP Staff:







Lori Morawski, MPH, CHES







Tamiko O’Brill, MS







Laura Laskosz, MPH







Instructional Designer:







Diane Guerriero







Name of Medium or Combination of Media Used

Internet course











Method of physician participation in the learning process

 







The EQIPP: Step Up Diabetes Care course requires you to do some work online and some offline. The online work involves reviewing the content presentation, researching linked information, and participating in guided activities. The offline work includes the performance improvement activities you will do within your own practice to improve the diabetes key activities in your practice.







Please note: CME credit is only awarded to learners who enter and analyze data. Using sample data provided by EQIPP will exclude learners from receiving AMA PRA Category 1 Credit(s)™ for the performance improvement activity portion of the course.







Estimated time to complete the educational activity







You may progress through the course at a pace that is comfortable for you, taking into consideration the demands of your practice. But it is important to establish a goal for completion. The amount of time you are likely to spend per clinical content area can vary depending on if you pursue additional links for more learning. You may also want to consider some elapsed time between sections to “catch your breath.”

Completion requirements for the Performance Improvement activity include:

1. Enter baseline data and analyze your results.







2. Create an improvement plan that has a minimum of 1 aim statement.







3. Document a minimum of 1 idea for change.







4. Enter data for a minimum of two follow up data set and analyze your results.







5. Submit a course evaluation.

Generally speaking, EQIPP: Step Up Diabetes Care course can be completed within 4-8 months, depending on the number of improvement cycles you make to reach the goals you have set for your practice. The American Board of Pediatrics (ABP) requires completion of two follow up data cycles to meet Maintenance of Certification (MOC) Part 4: Performance in Practice requirements. In EQIPP, a data cycle consists of Baseline data entry, an improvement plan, and followup data entry. You will be eligible to claim Performance Improvement (PI) Credit and notify the ABP upon completion of the 2nd follow up data cycles.







Dates of Original Release and Most Recent Review or Revision

This course was launched on June 4, 2013

Termination Date

This course will remain online until June 4, 2016. It will no longer be certified for credit after June 4, 2016.

List of Hardware/Software Requirements

 Recommended browsers:







• Internet Explorer 7.0 and above







• Firefox 3.0 and above







• Safari 5.0 and above







Recommended browser settings:







• JavaScript enabled







• Cookies enabled







• SSL 2.0 & SSL 3.0 enabled







• Flash Player Plug-in (version 7.0 +)







• Adobe Reader Plug-in (version 6.0 +)







Provider Contact information







If you have questions about this course or encounter technical problems, please contact PediaLink at [email protected].







Privacy and Confidentiality Statement

At the American Academy of Pediatrics, we take the issue of privacy very seriously. We do not sell, distribute, barter, or transfer personally identifiable information obtained from a user to a third party. Any information collected on the Web site is only used for the purpose stated.







The AAP list is only for important Academy communications, and your e-mail address will not be sold or provided to third parties. You will not receive advertising or promotional material on this list.







The American Academy of Pediatrics may use "cookie" technology to obtain non-personal information from its online visitors. We do not extract personal information in this process nor do we provide this information to third parties. We also do not contact you based on information in your cookie file.







The American Academy of Pediatrics has taken steps to make all information received from our online visitors as secure as possible against unauthorized access and use. All information is protected by our security measures, which are periodically reviewed.







Copyright© 2013 by the American Academy of Pediatrics All rights reserved.